Thymocyte contact or monoclonal antibody-mediated clustering of 3beta1 or 6beta4 integrins activate interleukin-6 (IL-6) transcription factors (NF-kappaB and NF-IL6) and IL-6 production in human thymic epithelial cells.
T-cell precursors develop within the thymus in contact with multiple supportive elements, among which thymic epithelial cells (TEC) are known to exert a dominant role in their homing, survival, and functional differentiation. All these functions are supported by cell-cell contacts and cytokine release. Signaling events triggered in lymphoid cells by adhesion to TEC are well characterized, but little is known about the opposite phenomenon. To address this issue, we derived cultures of TEC from human normal thymus. TEC monolayers were cocultured with thymocytes and immunostained with monoclonal antibodies (MoAbs) to integrin (2, 3, 4, and 6) and beta (beta1 and beta4) chains. Optical and confocal analysis showed that integrins were polarized on TEC at discrete surface locations: 6beta4 lined the basal surface of TEC monolayers, whereas 3beta1 was found mostly at TEC-TEC contacts; it is noteworthy that both 3beta1 and 6beta4 became highly enriched also at the boundaries with adherent thymocytes. Functional studies performed with MoAbs anti-beta1 and -beta4 integrins showed that beta1, and, to a much lower extent, beta4 heterodimers are involved in the TEC-thymocyte adhesion. Thymocyte contact or MoAb-mediated ligation of 3, 6, beta1, and beta4 integrins was investigated as a potential inducer of intracellular signaling in TEC. Thymocyte adhesion or cross-linking of MoAbs bound to integrins clustered at the TEC/thymocyte contact sites led to activation of interleukin-6 (IL-6) gene transcription factors, namely NF-IL6 serine phosphorylation and NF-kappaB nuclear targeting, as well as to increased IL-6 secretion. We propose that integrin clustering occurring during TEC-thymocyte contacts modulates in TEC the gene expression of a cytokine involved in thymocyte growth and functional differentiation.
Ramarli
D
D
Institute of Immunology and Infectious Diseases, University of Verona, Verona, Italy. dunia@borgoroma.univr.it>
Scupoli
M T
MT
Fiorini
E
E
Poffe
O
O
Brentegani
M
M
Villa
A
A
Cecchini
G
G
Tridente
G
G
Marchisio
P C
PC
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D015703:Antigens, CD / Q000276:immunology; D000954:Antigens, Surface / Q000502:physiology*; D051743:CCAAT-Enhancer-Binding Protein-delta; D022762:CCAAT-Enhancer-Binding Proteins; D002448:Cell Adhesion; D002450:Cell Communication; D002454:Cell Differentiation; D002478:Cells, Cultured; D002675:Child, Preschool; D018920:Coculture Techniques; D004268:DNA-Binding Proteins / Q000378:metabolism*; D019281:Dimerization; D004847:Epithelial Cells / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D007223:Infant; D039201:Integrin alpha3beta1; D039161:Integrin alpha6beta4; D019012:Integrin beta1 / Q000276:immunology; D039663:Integrin beta4; D016023:Integrins / Q000502:physiology*; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000235:genetics; D008024:Ligands; D016328:NF-kappa B / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism*; D011940:Receptor Aggregation / Q000187:drug effects / Q000502:physiology*; D013950:Thymus Gland / Q000166:cytology*; D014157:Transcription Factors; D014158:Transcription, Genetic
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000954:Antigens, Surface; D022762:CCAAT-Enhancer-Binding Proteins; C497252:CEBPD protein, human; D004268:DNA-Binding Proteins; D039201:Integrin alpha3beta1; D039161:Integrin alpha6beta4; D019012:Integrin beta1; D039663:Integrin beta4; D016023:Integrins; D015850:Interleukin-6; D008024:Ligands; D016328:NF-kappa B; D009687:Nuclear Proteins; D014157:Transcription Factors; D051743:CCAAT-Enhancer-Binding Protein-delta